Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. In Vivo Toxicology Market, by Product, 2019-2027 (USD Billion)
1.2.2. In Vivo Toxicology Market, by Test Type, 2019-2027 (USD Billion)
1.2.3. In Vivo Toxicology Market, by Toxicity Endpoints, 2019-2027 (USD Billion)
1.2.4. In Vivo Toxicology Market, by Testing Facility, 2019-2027 (USD Billion)
1.2.5. In Vivo Toxicology Market, by End-User, 2019-2027 (USD Billion)
1.2.6. In Vivo Toxicology Market, By Region, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global In Vivo Toxicology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global In Vivo Toxicology Market Dynamics
3.1. In Vivo Toxicology Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing pharmaceutical research and development activities
3.1.1.2. Growing demand for personalized medicine
3.1.2. Market Challenges
3.1.2.1. Stringent regulations and laws for the ethical use of animals in research
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for humanized animal models
Chapter 4. Global In Vivo Toxicology Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global In Vivo Toxicology Market, by Product
5.1. Market Snapshot
5.2. Global In Vivo Toxicology Market by Product, Performance - Potential Analysis
5.3. Global In Vivo Toxicology Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4. In Vivo Toxicology Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Consumables
5.4.2.1. Reagents & Kits
5.4.2.2. Animal Models
Chapter 6. Global In Vivo Toxicology Market, by Test Type
6.1. Market Snapshot
6.2. Global In Vivo Toxicology Market by Test Type, Performance - Potential Analysis
6.3. Global In Vivo Toxicology Market Estimates & Forecasts by Test Type 2018-2027 (USD Billion)
6.4. In Vivo Toxicology Market, Sub Segment Analysis
6.4.1. Acute
6.4.2. Sub-acute
6.4.3. Sub-chronic
6.4.4. Chronic test type
Chapter 7. Global In Vivo Toxicology Market, by Toxicity Endpoints
7.1. Market Snapshot
7.2. Global In Vivo Toxicology Market by Toxicity Endpoints, Performance - Potential Analysis
7.3. Global In Vivo Toxicology Market Estimates & Forecasts by Toxicity Endpoints 2018-2027 (USD Billion)
7.4. In Vivo Toxicology Market, Sub Segment Analysis
7.4.1. Immunotoxicity
7.4.2. Systemic toxicity
7.4.3. Carcinogenicity
7.4.4. Genotoxicity
7.4.5. Developmental & reproductive toxicity (DART)
7.4.6. Other
Chapter 8. Global In Vivo Toxicology Market, by Test facility
8.1. Market Snapshot
8.2. Global In Vivo Toxicology Market by Test facility, Performance - Potential Analysis
8.3. Global In Vivo Toxicology Market Estimates & Forecasts by Test facility 2018-2027 (USD Billion)
8.4. In Vivo Toxicology Market, Sub Segment Analysis
8.4.1. Outsourced testing facility
8.4.2. In-house testing facility
Chapter 9. Global In Vivo Toxicology Market, by End-User
9.1. Market Snapshot
9.2. Global In Vivo Toxicology Market by End-User, Performance - Potential Analysis
9.3. Global In Vivo Toxicology Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
9.4. In Vivo Toxicology Market, Sub Segment Analysis
9.4.1. Academic and Research Institutes
9.4.2. Pharmaceutical & Biotechnology Companies
9.4.3. Contract Research Organizations
9.4.4. Other
Chapter 10. Global In Vivo Toxicology Market, Regional Analysis
10.1. In Vivo Toxicology Market, Regional Market Snapshot
10.2. North America In Vivo Toxicology Market
10.2.1. U.S. In Vivo Toxicology Market
10.2.1.1. Product breakdown estimates & forecasts, 2018-2027
10.2.1.2. Test Type breakdown estimates & forecasts, 2018-2027
10.2.1.3. Toxicity Endpoints breakdown estimates & forecasts, 2018-2027
10.2.1.4. Test facility breakdown estimates & forecasts, 2018-2027
10.2.1.5. End-User breakdown estimates & forecasts, 2018-2027
10.2.2. Canada In Vivo Toxicology Market
10.3. Europe In Vivo Toxicology Market Snapshot
10.3.1. U.K. In Vivo Toxicology Market
10.3.2. Germany In Vivo Toxicology Market
10.3.3. France In Vivo Toxicology Market
10.3.4. Spain In Vivo Toxicology Market
10.3.5. Italy In Vivo Toxicology Market
10.3.6. Rest of Europe In Vivo Toxicology Market
10.4. Asia-Pacific In Vivo Toxicology Market Snapshot
10.4.1. China In Vivo Toxicology Market
10.4.2. India In Vivo Toxicology Market
10.4.3. Japan In Vivo Toxicology Market
10.4.4. Australia In Vivo Toxicology Market
10.5. Latin America In Vivo Toxicology Market Snapshot
10.5.1. Brazil In Vivo Toxicology Market
10.5.2. Mexico In Vivo Toxicology Market
10.6. Rest of The World In Vivo Toxicology Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profile
11.2.1. Charles River Laboratories
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. The Jackson Laboratory
11.2.3. Envigo
11.2.4. Taconic Biosciences, Inc.
11.2.5. JANVIER LABS
11.2.6. Thermo Fisher Scientific
11.2.7. Danaher Corporation
11.2.8. Waters Corporation
11.2.9. Agilent Technologies
11.2.10. Shimadzu Corporation
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption